FIELD: medicine; obstetrics.
SUBSTANCE: invention can be used to evaluate the effectiveness of tocolytic therapy with Nifedipine according to the following scheme: 20 mg orally, then after 30 minutes again 20 mg if uterine contractions persist, then 20 mg every 3–8 hours for 48 hours in patients with threatened or onset of premature labour. The level of vasopressin in venous blood is determined before and after tocolytic therapy. When this indicator decreases, therapy is considered effective.
EFFECT: method provides the opportunity to objectively assess the effectiveness of tocolytic therapy through laboratory testing of the level of vasopressin in the blood of patients.
1 cl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF PREGNANCY OUTCOME IN THREATENING PRETERM DELIVERY | 2020 |
|
RU2741500C1 |
| METHOD FOR PREDICTION OF PRETERM DELIVERY IN WOMEN WITH THREATENING LATE MISCARRIAGE AND RECURRENT MISCARRIAGE | 2024 |
|
RU2826778C1 |
| METHOD FOR THREATENING PREMATURE BIRTH DIAGNOSTICS | 2016 |
|
RU2630461C2 |
| METHOD FOR PREDICTING PREMATURE BIRTH IN WOMEN WITH THREATENED EARLY MISCARRIAGE AND RECURRENT MISCARRIAGE IN HISTORY | 2021 |
|
RU2755269C1 |
| METHOD FOR PREDICTION OF PREGNANCY TERMINATION IN THREATENED PRETERM LABOUR | 2010 |
|
RU2437097C1 |
| METHOD FOR PREDICTION OF SPONTANEOUS EARLY PRETERM DELIVERY | 2019 |
|
RU2729942C1 |
| METHOD FOR PREDICTION OF PRETERM DELIVERY AT GESTATION PERIOD OF 24-34 WEEKS | 2017 |
|
RU2670672C1 |
| METHOD FOR PREDICTING FOETAL GROWTH RETARDATION IN WOMEN WITH HIGH-RISK PREMATURE BIRTH | 2023 |
|
RU2806311C1 |
| METHOD FOR PREGNANCY OUTCOME PREDICTION OF IN CASE THREATENING PREMATURE DELIVERY | 2016 |
|
RU2630573C2 |
| METHOD FOR PREVENTION OF COMPLICATIONS IN PERITONEAL COMMISSURES GESTATION ACUTE INTESTINAL OBSTRUCTION IN PREGNANT WOMEN | 2015 |
|
RU2578541C1 |
